• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的人气道上皮细胞培养物独特地缺乏由其他冠状病毒引起的干扰素和立即早期基因反应。

SARS-CoV-2-infected human airway epithelial cell cultures uniquely lack interferon and immediate early gene responses caused by other coronaviruses.

作者信息

Wang Ying, Thaler Melissa, Salgado-Benvindo Clarisse, Ly Nathan, Leijs Anouk A, Ninaber Dennis K, Hansbro Philip M, Boedijono Fia, van Hemert Martijn J, Hiemstra Pieter S, van der Does Anne M, Faiz Alen

机构信息

PulmoScience Lab, Department of Pulmonology Leiden University Medical Center Leiden The Netherlands.

Department of Medical Microbiology Leiden University Medical Center Leiden The Netherlands.

出版信息

Clin Transl Immunology. 2024 Apr 15;13(4):e1503. doi: 10.1002/cti2.1503. eCollection 2024.

DOI:10.1002/cti2.1503
PMID:38623540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11017760/
Abstract

OBJECTIVES

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a member of a class of highly pathogenic coronaviruses. The large family of coronaviruses, however, also includes members that cause only mild symptoms, like human coronavirus-229E (HCoV-229E) or OC43 (HCoV-OC43). Unravelling how molecular (and cellular) pathophysiology differs between highly and low pathogenic coronaviruses is important for the development of therapeutic strategies.

METHODS

Here, we analysed the transcriptome of primary human bronchial epithelial cells (PBEC), differentiated at the air-liquid interface (ALI) after infection with SARS-CoV-2, SARS-CoV, Middle East Respiratory Syndrome (MERS)-CoV and HCoV-229E using bulk RNA sequencing.

RESULTS

ALI-PBEC were efficiently infected by all viruses, and SARS-CoV, MERS-CoV and HCoV-229E infection resulted in a largely similar transcriptional response. The response to SARS-CoV-2 infection differed markedly as it uniquely lacked the increase in expression of immediate early genes, including , and that was observed with all other coronaviruses. This finding was further confirmed in publicly available experimental and clinical datasets. Interfering with NR4A1 signalling in Calu-3 lung epithelial cells resulted in a 100-fold reduction in extracellular RNA copies of SARS-CoV-2 and MERS-CoV, suggesting an involvement in virus replication. Furthermore, a lack in induction of interferon-related gene expression characterised the main difference between the highly pathogenic coronaviruses and low pathogenic viruses HCoV-229E and HCoV-OC43.

CONCLUSION

Our results demonstrate a previously unknown suppression of a host response gene set by SARS-CoV-2 and confirm a difference in interferon-related gene expression between highly pathogenic and low pathogenic coronaviruses.

摘要

目的

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是一类高致病性冠状病毒的成员。然而,庞大的冠状病毒家族中也包括一些只会引起轻微症状的成员,如人类冠状病毒229E(HCoV-229E)或OC43(HCoV-OC43)。阐明高致病性和低致病性冠状病毒在分子(和细胞)病理生理学上的差异对于治疗策略的开发很重要。

方法

在此,我们使用批量RNA测序分析了原代人支气管上皮细胞(PBEC)在气液界面(ALI)分化后感染SARS-CoV-2、SARS-CoV、中东呼吸综合征(MERS)-CoV和HCoV-229E后的转录组。

结果

ALI-PBEC被所有病毒有效感染,SARS-CoV、MERS-CoV和HCoV-229E感染导致了大致相似的转录反应。对SARS-CoV-2感染的反应明显不同,因为它独特地缺乏包括 、 和 在内的立即早期基因表达的增加,而所有其他冠状病毒感染时都观察到了这种增加。这一发现在公开可用的实验和临床数据集中得到了进一步证实。干扰Calu-3肺上皮细胞中的NR4A1信号传导导致SARS-CoV-2和MERS-CoV的细胞外RNA拷贝数减少100倍,表明其参与病毒复制。此外,高致病性冠状病毒与低致病性病毒HCoV-229E和HCoV-OC43之间的主要区别在于缺乏干扰素相关基因表达的诱导。

结论

我们的结果证明了SARS-CoV-2对宿主反应基因集的一种前所未知的抑制作用,并证实了高致病性和低致病性冠状病毒在干扰素相关基因表达上的差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/156e/11017760/da3babe20f51/CTI2-13-e1503-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/156e/11017760/9d1cbd46047f/CTI2-13-e1503-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/156e/11017760/cb521fda0019/CTI2-13-e1503-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/156e/11017760/04fbc34379f0/CTI2-13-e1503-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/156e/11017760/0f410ff769da/CTI2-13-e1503-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/156e/11017760/2b72938907c9/CTI2-13-e1503-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/156e/11017760/d04186858aa3/CTI2-13-e1503-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/156e/11017760/da3babe20f51/CTI2-13-e1503-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/156e/11017760/9d1cbd46047f/CTI2-13-e1503-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/156e/11017760/cb521fda0019/CTI2-13-e1503-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/156e/11017760/04fbc34379f0/CTI2-13-e1503-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/156e/11017760/0f410ff769da/CTI2-13-e1503-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/156e/11017760/2b72938907c9/CTI2-13-e1503-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/156e/11017760/d04186858aa3/CTI2-13-e1503-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/156e/11017760/da3babe20f51/CTI2-13-e1503-g005.jpg

相似文献

1
SARS-CoV-2-infected human airway epithelial cell cultures uniquely lack interferon and immediate early gene responses caused by other coronaviruses.感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的人气道上皮细胞培养物独特地缺乏由其他冠状病毒引起的干扰素和立即早期基因反应。
Clin Transl Immunology. 2024 Apr 15;13(4):e1503. doi: 10.1002/cti2.1503. eCollection 2024.
2
Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses in differentiated primary human bronchial epithelial cells.人冠状病毒 229E 和 OC43 在分化的原代人支气管上皮细胞中复制并诱导不同的抗病毒反应。
Am J Physiol Lung Cell Mol Physiol. 2020 Dec 1;319(6):L926-L931. doi: 10.1152/ajplung.00374.2020. Epub 2020 Sep 9.
3
In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.紫锥菊制剂 Echinaforce®抗冠状病毒(包括普通感冒冠状病毒 229E 和 SARS-CoV-2)的体外病毒杀灭活性。
Virol J. 2020 Sep 9;17(1):136. doi: 10.1186/s12985-020-01401-2.
4
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.严重急性呼吸综合征冠状病毒 2 疫苗接种增强了对季节性人类冠状病毒的中和活性。
Clin Infect Dis. 2022 Aug 24;75(1):e653-e661. doi: 10.1093/cid/ciac057.
5
An overview on the seven pathogenic human coronaviruses.七种人类致病冠状病毒概述。
Rev Med Virol. 2022 Mar;32(2):e2282. doi: 10.1002/rmv.2282. Epub 2021 Aug 2.
6
Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.一种合成 STING 激动剂抑制原代人呼吸道系统中的冠状病毒感染。
Antiviral Res. 2021 Mar;187:105015. doi: 10.1016/j.antiviral.2021.105015. Epub 2021 Jan 12.
7
Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.转录组谱分析和人类冠状病毒(HCoV)-229E 感染人类细胞的基因组突变分析。
PLoS One. 2021 Feb 25;16(2):e0247128. doi: 10.1371/journal.pone.0247128. eCollection 2021.
8
Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection.通过揭示 SARS-CoV-2 编码蛋白的特征及其感染宿主后的反应,深入了解 SARS-CoV-2 疫情的发病机制。
Bioinformatics. 2021 Jan 29;36(21):5133-5138. doi: 10.1093/bioinformatics/btaa725.
9
Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.来源于日本健康供体的正常人静脉注射免疫球蛋白对 SARS-CoV-1/2、MERS-CoV 以及人类冠状病毒 229E 和 OC43 的中和及结合活性。
Transfusion. 2021 Feb;61(2):356-360. doi: 10.1111/trf.16161. Epub 2020 Oct 26.
10
Infection of primary nasal epithelial cells differentiates among lethal and seasonal human coronaviruses.原代鼻腔上皮细胞感染可区分致死性和季节性人冠状病毒。
Proc Natl Acad Sci U S A. 2023 Apr 11;120(15):e2218083120. doi: 10.1073/pnas.2218083120. Epub 2023 Apr 6.

引用本文的文献

1
Comparative analysis of organoid, air-liquid interface, and direct infection models for studying pathogen-host interactions in endometrial tissue.用于研究子宫内膜组织中病原体-宿主相互作用的类器官、气液界面和直接感染模型的比较分析
Sci Rep. 2025 Mar 12;15(1):8531. doi: 10.1038/s41598-025-93374-x.

本文引用的文献

1
Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures.从切除的肺组织中分离支气管上皮细胞用于生物库构建和建立良好分化的气液界面培养。
J Vis Exp. 2023 May 26(195). doi: 10.3791/65102.
2
An integrated cell atlas of the lung in health and disease.肺部健康与疾病的细胞整合图谱
Nat Med. 2023 Jun;29(6):1563-1577. doi: 10.1038/s41591-023-02327-2. Epub 2023 Jun 8.
3
Interferon regulatory factor 3 mediates effective antiviral responses to human coronavirus 229E and OC43 infection.
干扰素调节因子 3 介导针对人冠状病毒 229E 和 OC43 感染的有效抗病毒反应。
Front Immunol. 2023 May 1;14:930086. doi: 10.3389/fimmu.2023.930086. eCollection 2023.
4
Infection of primary nasal epithelial cells differentiates among lethal and seasonal human coronaviruses.原代鼻腔上皮细胞感染可区分致死性和季节性人冠状病毒。
Proc Natl Acad Sci U S A. 2023 Apr 11;120(15):e2218083120. doi: 10.1073/pnas.2218083120. Epub 2023 Apr 6.
5
Impact of Changes in Human Airway Epithelial Cellular Composition and Differentiation on SARS-CoV-2 Infection Biology.人类气道上皮细胞组成和分化变化对 SARS-CoV-2 感染生物学的影响。
J Innate Immun. 2023;15(1):562-580. doi: 10.1159/000530374. Epub 2023 Mar 25.
6
SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model.SARS-CoV-2 奥密克戎变异株在极化的人肺上皮细胞模型中复制能力减弱。
Commun Biol. 2022 Oct 27;5(1):1138. doi: 10.1038/s42003-022-04068-3.
7
Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1.与感染 H1N1 相比,感染 SARS-CoV-2 后气道上皮的免疫反应不同。
Mucosal Immunol. 2022 May;15(5):952-963. doi: 10.1038/s41385-022-00545-4. Epub 2022 Jul 15.
8
Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries.OAS1 无意义介导的衰变的遗传调控是导致欧洲和非洲血统的 COVID-19 住院患者发病的基础。
Nat Genet. 2022 Aug;54(8):1103-1116. doi: 10.1038/s41588-022-01113-z. Epub 2022 Jul 14.
9
Increased SARS-CoV-2 Infection, Protease, and Inflammatory Responses in Chronic Obstructive Pulmonary Disease Primary Bronchial Epithelial Cells Defined with Single-Cell RNA Sequencing.单细胞 RNA 测序定义的慢性阻塞性肺疾病原代支气管上皮细胞中 SARS-CoV-2 感染、蛋白酶和炎症反应增加。
Am J Respir Crit Care Med. 2022 Sep 15;206(6):712-729. doi: 10.1164/rccm.202108-1901OC.
10
Asymptomatic Transmissibility Calls for Implementing a Zero-COVID Strategy to End the Current Global Crisis.无症状传播呼吁实施零新冠病毒战略以结束当前的全球危机。
Front Cell Infect Microbiol. 2022 Apr 19;12:836409. doi: 10.3389/fcimb.2022.836409. eCollection 2022.